<DOC>
	<DOCNO>NCT02976987</DOCNO>
	<brief_summary>The infection high grade induce human papilloma virus cause precancerous lesion cervical epithelium . The progression lesion lead onset cervical cancer . To reduce risk cancer lesion classify 'cervical squamous intraepithelial neoplasia 2 ' ( CIN2 ) 'cervical squamous intraepithelial neoplasia 3 ' ( CIN3 ) , standard treatment conisation cervix . This surgery lead complication infertility risk preterm birth , hence need move towards non-surgical alternative therapy . The colvir clinical trial phase-II , multi center , randomize , double blind , efficacy study aqueous gel contain 2 % ( w/w ) cidofovir , administrate directly cervix exhibit high grade squamous intraepithelial lesion ( CIN 2 3 ) . This clinical trial prolongation colvir trial , order - ass long term histological virological evolution ( 24 month ) 3 g 2 % ( w/w ) cidofovir gel , administrate directly cervix exhibit high grade intraepithelial neoplasia complete response , partial response response failure end Colvir study . - ass long term ( 24 month ) rate recurrence histological lesion Colvir patient conisation , placebo treatment group .</brief_summary>
	<brief_title>A Prolongation Clinical Study Evaluate Efficacy Aqueous Gel Containing 2 % ( w/w ) Cidofovir , Directly Applied Cervix Exhibiting High Grade Squamous Intraepithelial Lesions .</brief_title>
	<detailed_description />
	<mesh_term>Squamous Intraepithelial Lesions Cervix</mesh_term>
	<mesh_term>Cidofovir</mesh_term>
	<criteria>Women participate COLVIR study receive complete treatment Women Colvir study receive incomplete treatment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Colvir</keyword>
	<keyword>high grade squamous intraepithelial lesion</keyword>
	<keyword>cervix</keyword>
</DOC>